KZIA Kazia Therapeutics announces the filing of provisional patent for novel strategy, supported by preclinical data, to prevent metastatic

KZIA Kazia Therapeutics announces the filing of provisional patent for novel strategy, supported by preclinical data, to prevent metastatic recurrence in triple-negative breast cancer